Schedule 13G ownership disclosure

N/A

Security class unavailable · CUSIP: 92539P101

Event date: 2021-06-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,495,571
Percent of class
5.1800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001787092-21-000001
Form type
SC 13G
Filer
Verve Therapeutics, Inc.
CIK
CIK 1840574
Filed
Jun 28, 2021
Reporting period
Jun 17, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub